deltatrials
Terminated NA INTERVENTIONAL 4-arm NCT02070705

DCE MRI in Patients With Pancreatic Cancer

The Use of Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE MRI) in the Management of Pancreatic Cancer

Sponsor: National Cancer Institute (NCI)

Updated 21 times since 2017 Last updated: Jul 8, 2025 Started: Jan 31, 2014 Primary completion: Aug 7, 2024 Completion: Aug 7, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Loss of funding

This NA trial investigates Familial Pancreatic Cancer and Pancreatic Adenocarcinoma and is currently terminated or withdrawn. National Cancer Institute (NCI) leads this study, which shows 21 recorded versions since 2014 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Nov 2019 · 14 months · monthly snapshot~Nov 2019 – ~May 2020 · 6 months · monthly snapshot~May 2020 – ~Oct 2020 · 5 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~Jun 2021 · 31 days · monthly snapshot~Jun 2021 – ~Mar 2022 · 9 months · monthly snapshot~Mar 2022 – ~Sep 2022 · 6 months · monthly snapshot~Sep 2022 – ~May 2023 · 8 months · monthly snapshot~May 2023 – ~Sep 2023 · 4 months · monthly snapshot~Sep 2023 – ~Mar 2024 · 6 months · monthly snapshot~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – ~Feb 2025 · 3 months · monthly snapshot~Feb 2025 – ~Aug 2025 · 6 months · monthly snapshot~Aug 2025 – ~Nov 2025 · 3 months · monthly snapshot~Nov 2025 – present · 9 months · monthly snapshot

Change History

21 versions recorded
  1. Nov 2025 — Present [monthly]

    Terminated NA

  2. Aug 2025 — Nov 2025 [monthly]

    Terminated NA

  3. Feb 2025 — Aug 2025 [monthly]

    Terminated NA

    Status: Active Not RecruitingTerminated

  4. Nov 2024 — Feb 2025 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  5. Sep 2024 — Nov 2024 [monthly]

    Recruiting NA

Show 16 earlier versions
  1. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  2. Mar 2024 — Jul 2024 [monthly]

    Recruiting NA

  3. Sep 2023 — Mar 2024 [monthly]

    Recruiting NA

  4. May 2023 — Sep 2023 [monthly]

    Recruiting NA

  5. Sep 2022 — May 2023 [monthly]

    Recruiting NA

  6. Mar 2022 — Sep 2022 [monthly]

    Recruiting NA

  7. Jun 2021 — Mar 2022 [monthly]

    Recruiting NA

  8. May 2021 — Jun 2021 [monthly]

    Recruiting NA

  9. Jan 2021 — May 2021 [monthly]

    Recruiting NA

  10. Oct 2020 — Jan 2021 [monthly]

    Recruiting NA

  11. May 2020 — Oct 2020 [monthly]

    Recruiting NA

  12. Nov 2019 — May 2020 [monthly]

    Recruiting NA

  13. Sep 2018 — Nov 2019 [monthly]

    Recruiting NA

  14. Jun 2018 — Sep 2018 [monthly]

    Recruiting NA

  15. Feb 2017 — Jun 2018 [monthly]

    Recruiting NA

  16. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • National Institute for Biomedical Imaging and Bioengineering (NIBIB)
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • OHSU Knight Cancer Institute
  • Oregon Health and Science University
Data source: OHSU Knight Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations